House‐dust‐mite sublingual‐swallow immunotherapy (SLIT) in perennial rhinitis: a double‐blind, placebo‐controlled study
- 1 April 2000
- Vol. 55 (4) , 369-375
- https://doi.org/10.1034/j.1398-9995.2000.00413.x
Abstract
Background: The safety and efficacy of sublingual‐swallow immunotherapy (SLIT) in rhinitis caused by house‐dust mite were evaluated in a double‐blind, placebo‐controlled study including 75 patients ...Keywords
This publication has 19 references indexed in Scilit:
- Sublingual‐swallow immunotherapy (SLIT) in patients with asthma due to house‐dust mites: a double‐blind, placebo‐controlled studyAllergy, 1999
- Immunotherapy as an effective tool in allergy treatmentAllergy, 1998
- Effect of a bed covering system in children with asthma and house dust mite hypersensitivityEuropean Respiratory Journal, 1997
- A combined approach to reduce mite allergen in the bedroomClinical and Experimental Allergy, 1995
- A double‐blind, placebo‐controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extractAllergy, 1994
- Changes in nasal specific IgE to mites after periods of allergen exposure‐avoidance: a comparison with serum levelsClinical and Experimental Allergy, 1994
- Prediction of mite allergen levels by guanine measurements in house‐dust samplesAllergy, 1993
- A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclassesJournal of Allergy and Clinical Immunology, 1990
- Specific immunotherapy in asthmaJournal of Allergy and Clinical Immunology, 1990
- Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust miteClinical and Experimental Allergy, 1988